Amanote Research
Register
Sign In
P2.16-43 Diabetes Is a Negative Prognostic Factor in Non-Small Cell Lung Cancer Patients Undergoing Resectional Surgery
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1518
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
I. Yasar
E. Şengül
B. Sozen
H.v. Kara
K. Kaynak
A. Turna
Publisher
Elsevier BV
Related search
P1.03-31 Periostin Is a Negative Prognostic Factor and Promotes Cancer Cell Proliferation in Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
BAP1 Is a Good Prognostic Factor in Advanced Non-Small Cell Lung Cancer
Clinical and Investigative Medicine
Medicine
P2.01-38 Sarcopenia Is Associated With Metastatic Burden and Is a Negative Prognostic Factor in Metastatic Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Indoleamine 2,3-Dioxygenase as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer
Journal of Clinical & Cellular Immunology
P084 Musashi-2 Expression Is an Prognostic Factor for Postoperative Survival in Patients With Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Comparison of Inflammation-Based Prognostic Scores in Patients Undergoing Curative Resection for Non-Small Cell Lung Cancer
World Journal of Oncology
Cancer Research
Oncology
P3.01-10 Dyspnea as a Prognostic Factor in Hispanic Patients With Non-Small Cell Lung Cancer Cohort
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Human Immunodeficiency Virus Infection as a Prognostic Factor in Surgical Patients With Non-Small Cell Lung Cancer
Annals of Thoracic Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Prognostic Significance of Diabetes Mellitus in Locally Advanced Non-Small Cell Lung Cancer
BMC Cancer
Cancer Research
Oncology
Genetics